학술논문
Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America
Document Type
Article
Author
Source
In Vaccine 16 June 2017 35(28):3591-3597
Subject
Language
ISSN
0264-410X